Skip to main content
. 2018 Apr 19;7(6):2753–2763. doi: 10.1002/cam4.1503

Table 4.

Treatments of the patients with breast cancer

Characteristics Total (N = 15,389) Premenopausal (N = 8395) Postmenopausal (N = 6994) P value
N % N % N %
Chemotherapy
Yes 12,437 80.77 7141 85.06 5296 75.72 <0.0001a
No 2294 14.90 960 11.44 1334 19.07
Missing data 668 4.34 294 3.50 374 5.35
Radiotherapy
Yes 2624 17.04 1705 20.31 919 13.14 <0.0001a
No 12,058 78.31 6373 75.91 5685 81.28
Missing data 707 4.59 317 3.78 390 5.58
Anti‐HER2 therapy
Yes 136 0.88 75 0.89 61 0.87 0.978a
No 14,571 94.63 8018 95.51 6553 93.69
Missing data 682 4.43 302 3.60 380 5.43
Endocrine therapy
Yes 4093 26.58 2499 29.77 1594 22.79 <0.0001a
No 10,584 68.74 5574 66.40 5010 71.63
Missing data 712 4.62 322 3.84 390 5.58
Type of surgery
Modified radical mastectomy 11,467 74.47 6061 72.20 5406 77.29 <0.0001a
Breast‐conserving surgery 1582 10.27 986 11.75 596 8.52
Simple mastectomy 793 5.15 451 5.37 342 4.89
Radical mastectomy 196 1.27 115 1.37 81 1.16
Extensive radical mastectomy 103 0.67 58 0.69 45 0.64
Breast reconstruction 380 2.47 314 3.74 66 0.94
Missing data 868 5.64 410 4.88 458 6.55
Axillary lymph node dissection
Yes 13,065 84.85 7145 85.11 5920 84.64 0.058a
No 1575 10.23 901 10.73 674 9.64
Missing data 749 4.86 349 4.16 400 5.72
Level of axillary lymph node dissection
Level I, II 9504 61.72 5220 62.18 4284 61.25 0.485a
Level III 1867 12.12 1009 12.02 858 12.27
Missing data 4018 26.09 2166 25.80 1852 26.48
a

Chi‐square test.